Εmmanouil Panagiotou

12PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Bioinformatic methods development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 27, 2026
Cancer Cell Metabolic Reprogramming: Dietary, Pharmacological Strategies and Clinical Perspectives.

|May 27, 2026
In-Treatment Kinetics of Peripheral Blood Immune Markers in PD-L1 High Non-Small Cell Lung Cancer and Prognostic Relevance for Immunotherapy Outcomes.

|Apr 14, 2026
Immunohistochemical Expression of IDO and PD-L1 in Distinct Compartments of Breast Cancer Tissue: Correlation with Clinicopathological Features and Outcomes.

Nikolaos Syrigos, Alexandros Mougiakos, Anastasia Konstantinidou

|Mar 27, 2026
Serum-Soluble Receptor for Advanced Glycation End Products as a Potential Biomarker in Lung Cancer Patients.

Emmanouil Panagiotou, Anastasia Georganta, Efstathios Garoflos

|Sep 15, 2025
Real-world safety and efficacy of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive/HER2-low metastatic breast cancer: a multicenter retrospective cohort study.

Elias Kotteas, Εmmanouil Panagiotou, Μaria Grammoustianou

|May 14, 2025
Robotic-Assisted Thoracoscopic Surgery Versus Video-Assisted Thoracoscopic Surgery: Which Is the Preferred Approach for Early-Stage NSCLC?

Nikolaos Syrigos, Eleni Fyta, Georgios Goumas

Pageof 2

Frequent Collaborators

4 joint publications

Ioannis Vathiotis

3 joint publications

Elias Kotteas

1 joint publications

Nikolaos K Syrigos

1 joint publications

Vassilis L Souliotis